The Kinston facility, which manufactures syringe plungers and other components of intravenous (IV) systems, has around 325 workers.
The Lionville, Pennsylvania-based firm intends to upgrade the Kinston plant with latest technologies to meet a growing demand for pharmaceutical products in the region.
West Pharmaceuticals chairman and CEO Don Morel said the choice to go with Kinston was driven by the quality of the local workforce, strong partnerships with state and local government and the geographic area, since Kinston will serve as a backup to a sister plant in Pennsylvania.